Invention Grant
- Patent Title: Chikungunya virus RNA vaccines
-
Application No.: US16853973Application Date: 2020-04-21
-
Publication No.: US11235052B2Publication Date: 2022-02-01
- Inventor: Giuseppe Ciaramella , Sunny Himansu , Eric Yi-Chun Huang , Tal Zaks , Sayda Mahgoub Elbashir
- Applicant: ModernaTX, Inc.
- Applicant Address: US MA Cambridge
- Assignee: ModernaTX, Inc.
- Current Assignee: ModernaTX, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: A61K39/12
- IPC: A61K39/12 ; A61K39/015 ; A61P11/00 ; A61K39/39 ; A61K39/42 ; A61K9/00 ; A61K9/127 ; A61K9/51 ; A61K48/00 ; A61K39/00
Abstract:
The disclosure relates to tropical diseases such as viral mosquito borne illnesses and the treatment thereof. The invention includes ribonucleic acid vaccines and combination vaccines, as well as methods of using the vaccines and compositions comprising the vaccines for treating and preventing tropical disease.
Public/Granted literature
- US20200289639A1 CHIKUNGUNYA VIRUS RNA VACCINES Public/Granted day:2020-09-17
Information query
